Ra Pharma (RARX) PT Lowered to $43 at Raymond James
Tweet
Share
E-mailGet Alerts RARX Hot Sheet
Price: $48.00 --0%
Rating Summary:
0 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 22
Rating Summary:
0 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 16 | New: 22
Join SI Premium – FREE
Raymond James analyst Steven Seedhouse lowered the price target on Ra Pharma (NASDAQ: RARX) to $43.00 (from $49.00) while maintaining a Strong Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades China Resources Cement Holdings (1313:HK) (CARCY) to Sell
- Snowflake Inc. (SNOW) PT Raised to $450 at Piper Sandler After 'Another Strong Beat'
- Ollie's Bargain Outlet (OLLI) PT Raised to $124 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Raymond JamesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
